http://rdf.ncbi.nlm.nih.gov/pubchem/reference/6154248

Outgoing Links

Predicate Object
contentType Journal Article|Meta-Analysis|Review|Systematic Review
endingPage 1110
issn 1476-5454
0950-222X
issueIdentifier 4
pageRange 1102-1110
publicationName Eye (London, England)
startingPage 1102
hasFundingAgency http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_7f19efd1a9e416cf0c2670fad4feb2d7
bibliographicCitation Duan J, Zhang Y, Zhang M. Efficacy and safety of the mineralocorticoid receptor antagonist treatment for central serous chorioretinopathy: a systematic review and meta-analysis. Eye (Lond). 2021 Apr;35(4):1102–10. PMID: 33414535; PMCID: PMC8115590.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9137fe389d3788dfc8786b5f58f9a09a
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-2633-6819
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3baedc999d657657877b3dfb45de106c
date 2021-01-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://pubmed.ncbi.nlm.nih.gov/33414535
https://doi.org/10.1038/s41433-020-01338-4
https://pubmed.ncbi.nlm.nih.gov/PMC8115590
isPartOf https://portal.issn.org/resource/ISSN/1476-5454
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/3725
https://portal.issn.org/resource/ISSN/0950-222X
language English
source https://www.crossref.org/
https://scigraph.springernature.com/
https://pubmed.ncbi.nlm.nih.gov/
title Efficacy and safety of the mineralocorticoid receptor antagonist treatment for central serous chorioretinopathy: a systematic review and meta-analysis
discusses http://id.nlm.nih.gov/mesh/M0570017
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_18e47f621cae9c76800b10c156cf224f
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_5fe86b5bd46c7a46650b62e23ce0459d
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11199

Total number of triples: 29.